- Report
- March 2023
- 80 Pages
Vietnam
From €1432EUR$1,500USD£1,199GBP
- Report
- March 2023
- 80 Pages
United States
From €1432EUR$1,500USD£1,199GBP
- Report
- March 2023
- 80 Pages
United Kingdom
From €1432EUR$1,500USD£1,199GBP
- Report
- March 2023
- 80 Pages
Poland
From €1432EUR$1,500USD£1,199GBP
- Report
- March 2023
- 80 Pages
Japan
From €1432EUR$1,500USD£1,199GBP
- Report
- February 2024
- 211 Pages
China
From €3818EUR$4,000USD£3,199GBP
- Report
- August 2023
- 320 Pages
Global
From €3407EUR$3,570USD£2,855GBP
- Report
- October 2022
- 157 Pages
Global
From €3407EUR$3,570USD£2,855GBP
Proton Pump Inhibitors (PPIs) are a class of drugs used to treat Gastrointestinal (GI) disorders. They work by reducing the amount of acid produced in the stomach, which helps to relieve symptoms of acid reflux, heartburn, and other GI conditions. PPIs are available in both prescription and over-the-counter forms, and are often used in combination with other medications to treat more severe GI conditions. Common side effects of PPIs include headache, nausea, and diarrhea.
PPIs are among the most widely prescribed drugs in the world, and are used to treat a variety of GI conditions. They are often used as a first-line treatment for acid reflux and other GI disorders, and are also used to prevent and treat ulcers.
Some of the major companies in the PPI market include AstraZeneca, Pfizer, Takeda, and GlaxoSmithKline. These companies produce a variety of PPIs, including omeprazole, lansoprazole, and pantoprazole. Show Less Read more